GMAB Latest Headlines

Genmab, Incyte team up to develop experimental colorectal cancer treatment

at seekingalpha.com (Sun, 25-Oct 2:56 PM)

Genmab rises, Corcept falls on late-stage antibody-conjugate data for ovarian cancer

at seekingalpha.com (Fri, 23-Oct 3:27 PM)

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Summit Therapeutics (SMMT) and Genmab (GMAB)

at www.tipranks.com (Fri, 23-Oct 1:10 PM)

Genmab’s Rina-S Delivers Breakthrough Phase 3 Results in Platinum-Resistant Ovarian Cancer

at www.tipranks.com (Fri, 23-Oct 12:18 PM)

Genmab A/S (0MGB) Receives a Buy from Barclays

at www.tipranks.com (Tue, 20-Oct 2:55 AM)

Genmab discloses Darwin Global stake at 5.11% of voting rights

Market Chameleon (Mon, 5-Oct 11:04 AM)

Genmab Highlights Rina-S Responses in Platinum-Resistant Ovarian Cancer, with 51% of Responders Still in Response at One Year

Market Chameleon (Mon, 5-Oct 7:08 AM)